经皮侵入性治疗方法在肺癌治疗中的应用现状与展望  

Performance and prospect of percutaneoas interventionai therapy in pulmonary neoplasm

作　　者：胡海洋[1] 李强[1] 

机构地区：[1]第二军医大学附属长海医院呼吸内科,上海200433

出　　处：《国际呼吸杂志》2007年第16期1264-1267,共4页International Journal of Respiration

摘　　要：经皮侵入性治疗作为一种新兴的肿瘤治疗方法,具有安全、微创、适应证广、并发症少等特点,对肺部肿瘤的治疗也可以达到很好的效果,明显优于现有的姑息性治疗方法。经皮侵入性治疗在肺癌综合治疗领域中的地位将日益突出。Percutaneous interventional therapy is a newly emerging way in pulmonary neoplasm,it is safe,minimally invasive with features of extensive indications and less complications. It has yielded good results in the treatment in pulmonary tumors,obviously surpassing other palliative therapies. The position of percutaneous interventional therapy in pulmonary neoplasm will be increasingly significant.

关 键 词：肺肿瘤 微创介入治疗 经皮侵入性治疗方法 肺癌 

分 类 号：R734[医药卫生—肿瘤]